Ravi A Madan, Clinical Researcher at the National Cancer Institute, shared a post on X:
“Lots of enthusiasm this important PSMA mtg.
Many great presentations projecting potential of PSMA but also a thoughtful if not sobering talk by Dr. Will Maguire, FDA Oncology.
‘PSMA PET endpoints not well suited to support accelerated approval at this time.’ ”
Other articles featuring Ravi A. Madan on OncoDaily.
